PT99657A - Processo para a preparacao de estereoisomeros de 7-{3-(1-amino-alquil)-1-pirrolidinil}-quinolonas e de composicoes farmaceuticas anti-bacterianas que os contem - Google Patents

Processo para a preparacao de estereoisomeros de 7-{3-(1-amino-alquil)-1-pirrolidinil}-quinolonas e de composicoes farmaceuticas anti-bacterianas que os contem

Info

Publication number
PT99657A
PT99657A PT99657A PT9965791A PT99657A PT 99657 A PT99657 A PT 99657A PT 99657 A PT99657 A PT 99657A PT 9965791 A PT9965791 A PT 9965791A PT 99657 A PT99657 A PT 99657A
Authority
PT
Portugal
Prior art keywords
stereoisomers
quinolones
preparation
pyrrolidinyl
amino
Prior art date
Application number
PT99657A
Other languages
English (en)
Other versions
PT99657B (pt
Inventor
John M Domagala
Mel Conrad Schroeder
John Steven Kiely
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PT99657A publication Critical patent/PT99657A/pt
Publication of PT99657B publication Critical patent/PT99657B/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyrrole Compounds (AREA)
PT99657A 1990-11-30 1991-11-29 Processo para a preparacao de estereoisomeros de 7-{3-(1-amino-alquil)-1-pirrolidinil}-quinolonas e de composicoes farmaceuticas anti-bacterianas que os contem PT99657B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62120190A 1990-11-30 1990-11-30
US73182591A 1991-07-15 1991-07-15

Publications (2)

Publication Number Publication Date
PT99657A true PT99657A (pt) 1992-12-31
PT99657B PT99657B (pt) 1999-05-31

Family

ID=27088892

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99657A PT99657B (pt) 1990-11-30 1991-11-29 Processo para a preparacao de estereoisomeros de 7-{3-(1-amino-alquil)-1-pirrolidinil}-quinolonas e de composicoes farmaceuticas anti-bacterianas que os contem

Country Status (14)

Country Link
EP (2) EP0559774B1 (pt)
JP (1) JPH06503565A (pt)
AT (1) ATE181915T1 (pt)
AU (2) AU658384B2 (pt)
CA (1) CA2095338C (pt)
DE (1) DE69131428T2 (pt)
DK (1) DK0559774T3 (pt)
ES (1) ES2137942T3 (pt)
GR (1) GR3031224T3 (pt)
IE (1) IE62205B1 (pt)
MX (1) MX9102290A (pt)
NZ (1) NZ240784A (pt)
PT (1) PT99657B (pt)
WO (1) WO1992009596A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU649893B1 (en) * 1991-11-25 1994-06-02 Warner-Lambert Company Antibacterial agents
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones
AU716479B2 (en) * 1993-05-06 2000-02-24 Pharmacia & Upjohn Company Optically active 3-(1-(alkylamino) alkyl pyrrolidines
US6140510A (en) * 1993-05-06 2000-10-31 Pharmacia & Upjohn Company Optically active 3-(1-(carbamoyl))alkyl-2-oxo-pyrrolidines and optically active 3-(1-(alkylamido))alkyl-2-oxo-pyrrolidines
EP0697015A1 (en) * 1993-05-06 1996-02-21 PHARMACIA & UPJOHN COMPANY Optically active 3-(1-(alkylamino))alkyl pyrrolidines
HUT77946A (hu) * 1994-11-18 1998-12-28 Pharmacia & Upjohn Co. Fluor-kinolon-származék fizikailag stabil, szilárd formája
US5929086A (en) 1996-05-10 1999-07-27 Pharmacia & Upjohn Company Topical administration of antimicrobial agents for the treatment of systemic bacterial diseases
DE69717988T2 (de) * 1996-05-10 2003-07-24 Pharmacia & Upjohn Co., Kalamazoo Topische verabreichung von premafloxacin zur behandlung von systemischen bakteriellen erkrankungen
KR100395779B1 (ko) * 2001-05-25 2003-08-21 한국화학연구원 임의적으로 베타-위치가 치환된 알파-아릴알킬기의 제거를통해 3급 아미드 화합물로부터 2급 아미드 화합물을제조하는 방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0207420B1 (en) * 1985-06-26 1992-05-06 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives
US4780468A (en) * 1987-08-07 1988-10-25 Warner-Lambert Company 8-trifluoromethyl quinolones as antibacterial agents
CA2012681A1 (en) * 1989-03-31 1990-09-30 Masayasu Okuhira Quinolone derivatives, preparation processes thereof, and antibacterial agents containing the same
US5157128A (en) * 1990-11-30 1992-10-20 Warner-Lambert Company Certain optically active substituted α,α-dialkyl-pyrrolidine-3-methamines useful as intermediates
KR950014567B1 (ko) * 1991-08-01 1995-12-08 주식회사대웅제약 신규한 퀴놀론 카르복실산 유도체

Also Published As

Publication number Publication date
CA2095338C (en) 2002-04-09
EP0559774A1 (en) 1993-09-15
DK0559774T3 (da) 2000-01-31
ES2137942T3 (es) 2000-01-01
MX9102290A (es) 1992-07-08
IE62205B1 (en) 1994-12-28
AU9057491A (en) 1992-06-25
AU658384B2 (en) 1995-04-13
NZ240784A (en) 1997-06-24
PT99657B (pt) 1999-05-31
WO1992009596A1 (en) 1992-06-11
DE69131428T2 (de) 2000-01-05
EP0559774B1 (en) 1999-07-07
ATE181915T1 (de) 1999-07-15
AU678715B2 (en) 1997-06-05
CA2095338A1 (en) 1992-05-31
IE914160A1 (en) 1992-06-03
EP0909759A3 (en) 2000-04-26
EP0909759A2 (en) 1999-04-21
DE69131428D1 (de) 1999-08-12
GR3031224T3 (en) 1999-12-31
JPH06503565A (ja) 1994-04-21
AU2334495A (en) 1995-09-07

Similar Documents

Publication Publication Date Title
PT89520A (pt) Processo para a preparacao de derivados de quinolino e acido naftiridino-carboxilicos substituidos por alquilo na posicao 5 e substituidos por um anel de piperazina ou pirrolidina na posicao 7 e de composicoes farmaceuticas que os contem
NO180490C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2,6-dialkyl-4-silylfenoler
BR8804098A (pt) Compostos,composicoes e processo para reducao da fitotoxidez de plantas de cultura
PT89502A (pt) Processo para a preparacao de derivados de 2-(2-hidroxi-3-fenoxi-metilo e de composicoes farmaceuticas que os contem
GB2210879B (en) 4h-1-benzopyran-4-one derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
MX9304756A (es) 9-[(glicilo substituido)amido]-6-desmetil-6-desoxitetraciclinas, metodo para su produccion y composiciones farmaceuticas que las contienen.
HN1998000074A (es) Derivados de macrolidos c-4 sustituidos
DK518683A (da) Fremgangsmaade til fremstilling af 4aeepi-9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a eller farmaceutisk acceptable syreadditionssalte deraf og mellemprodukter ved fremgangsmaaden
BR8707672A (pt) Pirazolinas inseticidas
MX9100990A (es) Compuesto monohidrato de furoato de mometasona,al procedimiento para su preparacion y a las composiciones farmaceuticas
MX9201356A (es) Derivados de piperidina, procedimiento para su preparacion y composicion farmaceutica que los contiene.
PT97905A (pt) Processo para a preparacao de composicoes farmaceuticas contendo derivados da cistina
PT88994A (pt) Processo para a preparacao de 2',3'-didesoxi-2'-fluoro-nucleosidos e de composicoes farmaceuticas que os contem
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
PT99657A (pt) Processo para a preparacao de estereoisomeros de 7-{3-(1-amino-alquil)-1-pirrolidinil}-quinolonas e de composicoes farmaceuticas anti-bacterianas que os contem
ES2045009T3 (es) El acido taurohyodesoxicolico para la terapia de calculosis del tracto biliar y de la dispepsia biliar.
PT93702A (pt) Processo para a preparacao de 2,7-diazabiciclo{3.3.0}octanos e de produtos intermediarios
PT96166A (pt) Processo para a preparacao de derivados de benzo{b}tiofeno
PT99658A (pt) Processo para a preparacao de 7-{3-(1,1-dialquil-metil-1-amino-1-pirrolidinil}-quinolonas e naftiridonas e de composicoes farmaceuticas anti-bacterianas que os contem
PT87930A (pt) Processo para a preparacao de derivados de acido 3-desmetil-4-fluor-mevalonico e de composicoes farmaceuticas que os contem
ES2037763T3 (es) Metodo para preparar compuestos no naturales afines a la ceramida.
ES2148458T3 (es) Derivados de fenil-4-tiazoles sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
PT96887A (pt) Processo para a preparacao de novas oxetanonas com accao inibidora da lipase pancreatica e de composicoes farmaceuticas que as contem
ES2138100T3 (es) Procedimiento para la preparacion de 1,5-benzotiazepinas por ciclizacion de esteres aminicos.
BR8806001A (pt) Processo para producao de composto e composicao inseticida

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920814

FG3A Patent granted, date of granting

Effective date: 19990208

MM3A Annulment or lapse

Effective date: 20060808